Eszopigard-3 mg Tablets: High-Potency Non-Benzodiazepine Hypnotic for Global Institutional Supply Chains In-Depth Product Analysis & Clinical Profile Eszopigard-3 mg Tablet is a highly specialized oral sleep-induction medication engineered for targeted clinical intervention in severe sleep architectural disruptions. Each tablet contains exactly 3 mg of Eszopiclone USP, a highly pure non-benzodiazepine hypnotic agent belonging to the cyclopyrrolone chemical class, recognized worldwide as a therapeutic standard for complex sleep maintenance disorders. Clinical Indications & Therapeutic Scope Severe Sleep Maintenance Insomnia: Specifically formulated for patients who experience frequent, abnormal nighttime awakenings, helping them achieve a continuous, deep, and stable sleep cycle throughout the night. Chronic and Transient Insomnia: Indicated to significantly reduce sleep onset latency (the total time taken to fall asleep) and extend total sleep duration in patients whose circadian rhythms have been disrupted by neurological imbalances, somatic stress, or situational trauma. Chronic and Transient Insomnia: Indicated to significantly reduce sleep onset latency (the total time taken to fall asleep) and extend total sleep duration in patients whose circadian rhythms have been disrupted by neurological imbalances, somatic stress, or situational trauma. Physiological Mechanism of Action Selective GABA-A Receptor Modulation: Eszopiclone functions as a highly selective positive allosteric modulator that binds to the gamma-aminobutyric acid- receptor complex. It targets specific receptor sub-units at a site distinct from traditional benzodiazepine molecules. Chloride Channel Amplification: By enhancing the affinity of the receptor for endogenous (the central nervous system's primary inhibitory neurotransmitter), it triggers a greater influx of chloride ions into the post-synaptic neurons. Neuronal Hyperpolarization and Sedation: This ion influx induces post-synaptic cellular hyperpolarization, slowing down overactive neuronal firing across the brain's arousal centers. This calms the central nervous system, promotes muscle relaxation, and establishes the ideal physiological state for deep, restorative sleep. Technical Storage, Stability, and Handling Protocols Temperature Restrictions: Store Eszopigard-3 mg Tablets at controlled room temperature, ideally between 15°C to 30°C (59°F to 86°F). Moisture & Ultraviolet Mitigation: Keep the tablets sealed within their original factory blister packaging or high-barrier commercial containers. Protect the cargo from high humidity, steam, or direct exposure to sunlight. Inventory Safety: Store in a locked, secure pharmaceutical repository suitable for controlled prescription medications, completely separated from standard retail products and out of reach of minors. Comprehensive Clinical Side Effects & Tolerability Dysgeusia (Taste Alteration): A unique and highly common side effect characterized by a sharp, unpleasant, bitter, or metallic taste in the mouth immediately upon waking. Dysgeusia (Taste Alteration): A unique and highly common side effect characterized by a sharp, unpleasant, bitter, or metallic taste in the mouth immediately upon waking. Gastrointestinal and Mucosal Effects: Potential reactions include distinct dry mouth (xerostomia), mild nausea, dyspepsia, and a minor increase in susceptibility to mild respiratory tract infections due to secondary mucosal drying. International Regulatory Documentation & Quality Portfolios Certificate of Analysis (COA): Comprehensive laboratory validation proving exact 3 mg active ingredient concentration per unit, batch uniformity, dissolution rates, and absolute chemical purity. Certificate of Origin (COO): Officially stamped documentation verifying that the formulation was produced in an authorized, certified Indian pharmaceutical manufacturing facility. Customs-Ready Trade Manifesting: Detailed packing slips, commercial invoices, dangerous goods or restricted substance transport declarations, and correct Harmonized System (HS) import codes to ensure efficient processing through international border networks. PRESCRIPTION MEDICINE IS YES Clinical Disclaimer: This product summary is compiled strictly for international wholesale distribution networks, and digital optimization indexing. Eszopigard-3 mg Tablets (Eszopiclone) are highly potent, restricted prescription medications that carry a risk of misuse and dependency. This drug must be administered exclusively under the direct guidance and clinical evaluation of a licensed physician or psychiatrist. 📞 Contact Ernest Impex — Pharmaceutical Exporter from India [GROUP OF ERNEST PHARMACEUTICAL PVT. LTD.] 🌐 Websites: www.ernestimpex.com www.ernestvision.com www.oncologymedicinesupplier.com www.ernestpharmaceuticals.com 📧 Email: exports@ernestpharmaceuticals.com 📦 Business Type: Exporter | Bulk Supplier | Distributor 📲 WhatsApp: +91 93599 02383